Condiciones de salud que Artemisa puede ayudar a apoyar.
A. vulgaris has demonstrated antispasmodic activity on smooth muscle via dual muscarinic receptor blockade and calcium channel inhibition, providing a mechanistic basis for relief of abdominal cramping. Its traditional use across Chinese, Hindu, and European systems for gastrointestinal complaints is pharmacologically corroborated. Herb preparations promote gastric juice secretion and relax GI tract and bile ducts.
Numerous laboratory studies have documented potent antioxidant activity in A. vulgaris extracts, attributed to flavonoids, phenolic acids, and essential oil components. DPPH, ABTS, and FRAP assays consistently show strong free-radical scavenging capacity. A rodent study found that extract treatment normalized serum malondialdehyde and increased paraoxonase-1 activity, markers of improved antioxidant status.
A. vulgaris is traditionally used to treat arthritis and gout in Vietnamese medicine, and preclinical studies confirm xanthine oxidase inhibitory and anti-inflammatory activities relevant to gout. Moxibustion has been clinically studied for osteoarthritis pain. Flavonoids in mugwort suppress inflammatory cytokines implicated in joint inflammation.
Aqueous extracts of A. vulgaris reversed noradrenaline-induced hypertension in isolated rat mesentery preparations, and moxibustion at acupoint KI 1 has shown blood-pressure-lowering effects in RCTs reviewed in a systematic review. Vasodilatory and hypotensive effects have been documented in animal models. Clinical data from moxibustion RCTs provide the most direct human-level evidence.
The antispasmodic and bronchodilator effects of A. vulgaris have been pharmacologically demonstrated to operate via dual blockade of muscarinic receptors and calcium influx on airway smooth muscle. This is one of the plant's better-characterized pharmacological mechanisms. The major constituent 1,8-cineole additionally provides mucolytic and broncholytic activity. Evidence is preclinical; no human clinical trials exist.
A. vulgaris essential oil has demonstrated significant antifungal activity against Candida albicans in laboratory disc-diffusion assays, with inhibition zones exceeding those of standard antifungals such as ketoconazole. Antifungal activity is attributed to 1,8-cineole, α-thujone, and camphene. Evidence is in vitro only; no human clinical trials exist.
A. vulgaris extracts have demonstrated hypolipidemic effects in rodent models of diet-induced hypercholesterolemia, normalizing total cholesterol, LDL, VLDL, triglycerides, and HDL. The mechanism is proposed to involve inhibition of hepatic HMG-CoA reductase. These findings are preclinical only; no human trials have been conducted.
Multiple preclinical studies demonstrate that A. vulgaris extracts suppress inflammatory mediators including TNF-α, NO, and prostaglandins in rodent models. Ethyl acetate and ethanolic leaf extracts significantly inhibited formalin-induced paw edema in vivo. The key bioactive compounds — flavonoids such as luteolin and quercetin, plus 1,8-cineole — are established anti-inflammatory agents. No controlled human trials have yet translated these findings.
A. vulgaris essential oil demonstrates in vitro antifungal activity relevant to skin pathogens, and the plant is used in CosIng-recognized cosmetic formulations. Multiple preclinical studies confirm activity against Candida albicans and bacterial skin pathogens. Evidence is preclinical and cosmetic; no clinical dermatological antifungal trials exist.
Hepatoprotective activity of A. vulgaris aqueous-methanol extract has been demonstrated in rodent models, with normalization of elevated liver enzymes and protection of hepatocytes against oxidative stress. The plant is listed in TCM for hepatitis and its choleretic (bile-stimulating) action is documented. Preclinical findings only; no human hepatoprotection trials exist.
NCCIH reports a preliminary clinical study in which a topical lotion containing mugwort and menthol relieved itching associated with hypertrophic scars. The multi-ingredient nature of the product means mugwort's specific contribution is uncertain. Mugwort is also used in cosmetic formulations recognized by the European CosIng database for skin protective effects.
A. vulgaris is recorded in Ayurvedic root preparations and the European Pharmacopoeia homeopathic listings for anxiety and nervous disorders. Related Artemisia species contain constituents (ursolic acid, oleanolic acid, carnosol) that modulate GABA-A receptors via the benzodiazepine binding site, demonstrating anxiolytic effects in rodent models. No human clinical trials on anxiety for A. vulgaris specifically exist.
Mugwort has been recorded as a bitter digestive tonic and appetizer across traditional European and Asian herbal systems. The bitter sesquiterpene lactones in the plant stimulate gastric secretion, which is the classical mechanism of herbal appetite stimulants. No human clinical trials support this use.
Adams et al. (Chinese Medicine, 2012) reviewed mugwort species specifically for ADHD treatment, representing the primary source linking A. vulgaris to this indication. The MAO-inhibitory phenolics and CNS-active volatile constituents provide mechanistic plausibility. Evidence is entirely traditional and review-based, with no dedicated human trials.
In TCM, moxibustion with A. vulgaris is believed to stimulate blood flow and qi at acupuncture points, and this is one of its central traditional mechanisms. The antithrombotic properties of borneol (a constituent of the essential oil) are documented in vitro. European medieval medicine used mugwort to 'remove leg fatigue.' No oral supplementation circulation trials exist.
Mugwort is recorded in European herbal tradition as having a laxative effect used to relieve constipation. The Springer pharmacological review notes that its herb preparations produce an experimental laxative effect recognized in European practice. Moxibustion has also been cited as used for constipation in TCM. No clinical trials on oral mugwort for constipation exist.
A. vulgaris is documented in Ayurvedic, Asian, and European traditional medicine for depression, with MAO-inhibiting phenolics and GABA-A modulating constituents providing mechanistic plausibility. A non-peer-reviewed source cites a clinical observation of mugwort reducing depressive symptoms, but no controlled human trial data exist.
Mugwort features in medieval European and Asian traditions as a remedy for diarrhea, referenced in the context of gastrointestinal complaints 'resulting from cold.' The antispasmodic and astringent properties of the plant provide pharmacological plausibility. No clinical trials on mugwort for diarrhea exist.
A. vulgaris is documented in European Pharmacopoeia homeopathic preparations and multiple ethnomedicinal systems for epilepsy and convulsive disorders. GABA-A receptor modulation by Artemisia constituents provides a mechanistic basis for anticonvulsant activity. One source describes seizure reduction in epileptic patients through moxibustion therapy, but controlled clinical evidence is absent.
In TCM, mugwort ('Ai Ye') is specifically used for cold-type infertility combined with kidney yang tonics, and moxibustion at BL 67 is used for uterine positioning to support fertility. The plant's estrogenic and uterotonic properties support this traditional use. No human clinical fertility trials with oral mugwort exist.
A. vulgaris has been used as an antipyretic (fever-reducing herb) in traditional European, Ayurvedic, and Asian folk medicine. Medieval European medicine specifically recommended it for fever. The entire plant is used for antipyretic purposes in Himalayan folk medicine documented in ethnobotanical literature. No clinical trials support this use.
Mugwort is traditionally used as a choleretic — stimulating bile production and secretion from the gallbladder — in European herbal medicine. This use is documented in the traditional European herbal record and is pharmacologically plausible given the plant's bitter sesquiterpene lactone content. No clinical trials evaluate this indication directly.
A. vulgaris is documented in European Pharmacopoeia-recognized homeopathic preparations and multiple traditional systems for insomnia and sleep disorders including somnambulism. MAO-inhibiting phenolic compounds in the plant provide mechanistic plausibility for nervous system sedation. No human clinical sleep trials with mugwort exist.
Regulating irregular menstrual cycles is one of the oldest and most consistently documented traditional uses of A. vulgaris across European, Chinese, and Hindu medicine. The European Pharmacopoeia lists it in homeopathic preparations for this purpose. Its estrogenic activity and uterotonic properties from sesquiterpene lactones provide pharmacological plausibility, but no human RCTs exist for oral use.
A. vulgaris has a traditional role as an expectorant and is used for bronchitis, colds, and respiratory complaints in European and Asian folk medicine. The constituent 1,8-cineole (eucalyptol) has documented mucolytic, broncholytic, and anti-inflammatory properties. No human clinical trials on mugwort for lung health exist.
A. vulgaris is documented for treatment of menopausal symptoms in the European Pharmacopoeia (as a homeopathic preparation) and in TCM tradition. The plant's estrogenic activity, confirmed in pharmacological studies, provides mechanistic support. Adams et al. (Chinese Medicine 2012) specifically reviewed mugwort for menopause. Moxibustion is clinically used for hot flashes. No oral supplementation RCTs for menopause exist.
Mugwort (Artemisia vulgaris) is one of the oldest traditional herbal remedies for menstrual cramps and irregularity, used as an emmenagogue and antispasmodic across East Asian, European, and indigenous traditions. It is used in Traditional Chinese Medicine (moxibustion and internal) specifically for cold-type dysmenorrhea. Scientific clinical trial evidence for oral use in dysmenorrhea is limited.
Mugwort has been historically classified as a digestive and antiemetic herb in traditional European and Asian medicine. Its antispasmodic action on smooth muscle and its documented use against nausea — including fever-related nausea — are found in multiple ethnobotanical records. No human clinical trials exist for this indication.
A. vulgaris is documented as an antiparasitic and anthelmintic (worm-expelling) herb across European, Asian, and Ayurvedic traditions. The plant's use against intestinal worms is one of its oldest recorded applications. Preclinical evidence supports antiparasitic activity of Artemisia species generally. No human clinical trials specifically on A. vulgaris for parasites exist.
Mugwort is documented in traditional Chinese medicine for premenstrual syndrome, and moxibustion has been studied in a clinical context for reducing premenstrual cramping. Adams et al. (Chinese Medicine, 2012) specifically reviewed mugwort for PMS treatment. Human evidence is from moxibustion applications rather than oral supplementation.
Mugwort has a long-standing traditional use for promoting dream vividness and overall sleep quality, attributed to thujone's GABA-A modulation and MAO-inhibiting phenolics. It appears in the European Pharmacopoeia for sleep-adjacent nervous disorders. No human RCTs have measured objective sleep outcomes.
Multiple ethnomedicinal systems document A. vulgaris for stress and nervous tension, particularly the root as an adaptogenic tonic in Ayurveda. TCM moxibustion is used for stress reduction. Mechanistic support comes from sedative and MAO-inhibiting properties of plant constituents. No human RCTs exist.
A. vulgaris has a centuries-long tradition of use for uterine health in TCM, European, and Hindu medicine, including for threatened miscarriage, uterine bleeding, and uterine positioning (via moxibustion). Moxibustion RCTs for breech presentation demonstrate the most direct human clinical evidence of uterine-relevant effects. The plant's estrogenic and uterotonic pharmacology provides mechanistic support.
Medieval European medicine used A. vulgaris externally for wound treatment, and its antibacterial, anti-inflammatory, and antioxidant properties provide pharmacological plausibility. Leaf poultices for wounds are documented across multiple folk traditions. No dedicated clinical wound-healing trials with A. vulgaris exist.
Volver